Investor Hub

Novavax, Inc. is a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases.

Latest investor presentation
Latest clinical presentation
Latest quarterly earnings
Annual report
Latest publications, posters & presentations
Global ticker
NASDAQNVAX
NASDAQNVAX
FormDescriptionDateFormat
10-QQuarterly report which provides a continuing view of a company's financial positionNov 7, 2018Open Quarterly report which provides a continuing view of a company's financial position in HTML.Open Quarterly report which provides a continuing view of a company's financial position in DOC file.Open Quarterly report which provides a continuing view of a company's financial position in PDF file.Open Quarterly report which provides a continuing view of a company's financial position in XLS file.Open Quarterly report which provides a continuing view of a company's financial position in XBLR Viewer.Open Quarterly report which provides a continuing view of a company's financial position in XBLR file.
10-QQuarterly report which provides a continuing view of a company's financial positionAug 8, 2018Open Quarterly report which provides a continuing view of a company's financial position in HTML.Open Quarterly report which provides a continuing view of a company's financial position in DOC file.Open Quarterly report which provides a continuing view of a company's financial position in PDF file.Open Quarterly report which provides a continuing view of a company's financial position in XLS file.Open Quarterly report which provides a continuing view of a company's financial position in XBLR Viewer.Open Quarterly report which provides a continuing view of a company's financial position in XBLR file.
10-QQuarterly report which provides a continuing view of a company's financial positionMay 9, 2018Open Quarterly report which provides a continuing view of a company's financial position in HTML.Open Quarterly report which provides a continuing view of a company's financial position in DOC file.Open Quarterly report which provides a continuing view of a company's financial position in PDF file.Open Quarterly report which provides a continuing view of a company's financial position in XLS file.Open Quarterly report which provides a continuing view of a company's financial position in XBLR Viewer.Open Quarterly report which provides a continuing view of a company's financial position in XBLR file.
Why invest with us

We are a biotechnology company that promotes improved health globally through the discovery, development and commercialization of innovative vaccines to prevent serious infectious diseases.

For much of my four-decade career, I’ve worked with biotech companies trying to solve significant health challenges, including HIV. Novavax is uniquely positioned to help end this pandemic with our protein-based vaccine. I believe in NVX-CoV2373 so much.

I came out of retirement to join the fight.

Lisa Dunkle
Vice President, Global Medical Lead for Coronavirus Vaccine

Get notifications for investor updates

Sign up for notifications from Novavax including upcoming events, webcasts, research updates, daily stock closings, SEC filings, and more.

Go to email subscription 

Investor inquiries

Shareholders seeking information can contact investor relations at (240) 268-2022 or email us at ir@novavax.com

Novavax corporate policy prohibits any employees, other than designated spokespersons, from communicating with its investors.